Practice Guideline
doi: 10.1016/j.kint.2020.06.019.
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Collaborators
- PMID: 32998798
- DOI: 10.1016/j.kint.2020.06.019
Item in Clipboard
Practice Guideline
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Kidney Int.
2020 Oct.
Free article
No abstract available
Comment in
-
Chronic Kidney Disease in Diabetes: Guidelines from KDIGO.Am Fam Physician. 2021 Jun 1;103(11):698-700. Am Fam Physician. 2021. PMID: 34060786 No abstract available.
-
KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease.Kidney Int. 2022 Feb;101(2):420. doi: 10.1016/j.kint.2021.11.020. Epub 2021 Dec 11. Kidney Int. 2022. PMID: 34906417 Free PMC article. No abstract available.
-
The authors reply.Kidney Int. 2022 Feb;101(2):420-421. doi: 10.1016/j.kint.2021.11.019. Epub 2021 Dec 11. Kidney Int. 2022. PMID: 34906418 No abstract available.
Similar articles
-
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.Kidney Int. 2022 Nov;102(5S):S1-S127. doi: 10.1016/j.kint.2022.06.008. Kidney Int. 2022. PMID: 36272764 No abstract available.
-
Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions.BMJ. 2017 Apr 11;357:j1420. doi: 10.1136/bmj.j1420. BMJ. 2017. PMID: 28400361 Review. No abstract available.
-
Diagnosis and treatment of diabetic kidney disease.Am J Med Sci. 2014 May;347(5):406-13. doi: 10.1097/MAJ.0000000000000185. Am J Med Sci. 2014. PMID: 24553399 Review.
-
Diabetes/Kidney/Heart Disease.Cardiol Clin. 2019 Aug;37(3):ix-x. doi: 10.1016/j.ccl.2019.04.011. Epub 2019 May 15. Cardiol Clin. 2019. PMID: 31279429 No abstract available.
-
The KDIGO guidelines on diabetes and chronic kidney disease, 2020: An appraisal.Diabet Med. 2021 Jul;38(7):e14561. doi: 10.1111/dme.14561. Epub 2021 Mar 31. Diabet Med. 2021. PMID: 33772854 No abstract available.
Cited by
-
Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus.Mayo Clin Proc Innov Qual Outcomes. 2022 Oct 15;6(6):536-551. doi: 10.1016/j.mayocpiqo.2022.09.002. eCollection 2022 Dec. Mayo Clin Proc Innov Qual Outcomes. 2022. PMID: 36277502 Free PMC article. Review.
-
Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control.Int J Mol Sci. 2021 Apr 22;22(9):4374. doi: 10.3390/ijms22094374. Int J Mol Sci. 2021. PMID: 33922132 Free PMC article. Review.
-
Inflammatory indexes and anemia in chronic kidney disease: correlation and survival analysis of the National Health and Nutrition Examination Survey 2005-2018.Ren Fail. 2024 Dec;46(2):2399314. doi: 10.1080/0886022X.2024.2399314. Epub 2024 Sep 9. Ren Fail. 2024. PMID: 39248404 Free PMC article.
-
Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus.Front Endocrinol (Lausanne). 2023 Nov 22;14:1274025. doi: 10.3389/fendo.2023.1274025. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38075072 Free PMC article.
-
Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway.Int J Mol Sci. 2024 Jul 28;25(15):8235. doi: 10.3390/ijms25158235. Int J Mol Sci. 2024. PMID: 39125805 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
